PL342886A1 - Novel nucleic acid transfer agents, compositions containing same and uses - Google Patents
Novel nucleic acid transfer agents, compositions containing same and usesInfo
- Publication number
- PL342886A1 PL342886A1 PL99342886A PL34288699A PL342886A1 PL 342886 A1 PL342886 A1 PL 342886A1 PL 99342886 A PL99342886 A PL 99342886A PL 34288699 A PL34288699 A PL 34288699A PL 342886 A1 PL342886 A1 PL 342886A1
- Authority
- PL
- Poland
- Prior art keywords
- nucleic acid
- compositions containing
- transfer agents
- containing same
- novel nucleic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/48—Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
- C07D239/12—Nitrogen atoms not forming part of a nitro radical
- C07D239/14—Nitrogen atoms not forming part of a nitro radical with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9804121A FR2777017B1 (en) | 1998-04-02 | 1998-04-02 | NOVEL NUCLEIC ACID TRANSFER AGENTS, COMPOSITIONS CONTAINING THEM AND USES THEREOF |
| US8584598P | 1998-05-18 | 1998-05-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL342886A1 true PL342886A1 (en) | 2001-07-16 |
Family
ID=26234240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL99342886A PL342886A1 (en) | 1998-04-02 | 1999-03-30 | Novel nucleic acid transfer agents, compositions containing same and uses |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1068188A1 (en) |
| JP (1) | JP2002513543A (en) |
| KR (1) | KR20010042318A (en) |
| CN (1) | CN1294582A (en) |
| AU (1) | AU759301B2 (en) |
| BR (1) | BR9909350A (en) |
| CA (1) | CA2324931A1 (en) |
| HU (1) | HUP0102455A3 (en) |
| IL (1) | IL138625A0 (en) |
| NO (1) | NO317225B1 (en) |
| PL (1) | PL342886A1 (en) |
| WO (1) | WO1999051581A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020091242A1 (en) | 2000-10-11 | 2002-07-11 | Michel Bessodes | Acid-sensitive compounds, their preparation and uses |
| ITMI20050222A1 (en) | 2005-02-15 | 2006-08-16 | Milano Politecnico | CATION LIPIDS FOR THE TRANSFORMATION OF NUCLEIC ACIDS |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2645866B1 (en) * | 1989-04-17 | 1991-07-05 | Centre Nat Rech Scient | NEW LIPOPOLYAMINES, THEIR PREPARATION AND THEIR USE |
| US5283185A (en) * | 1991-08-28 | 1994-02-01 | University Of Tennessee Research Corporation | Method for delivering nucleic acids into cells |
| FR2714830B1 (en) * | 1994-01-10 | 1996-03-22 | Rhone Poulenc Rorer Sa | Composition containing nucleic acids, preparation and uses. |
| FR2727679B1 (en) * | 1994-12-05 | 1997-01-03 | Rhone Poulenc Rorer Sa | NEW TRANSFECTION AGENTS AND THEIR PHARMACEUTICAL APPLICATIONS |
| FR2741066B1 (en) * | 1995-11-14 | 1997-12-12 | Rhone Poulenc Rorer Sa | NEW TRANSFECTION AGENTS AND THEIR PHARMACEUTICAL APPLICATIONS |
| DK0888379T3 (en) * | 1996-03-01 | 2001-01-29 | Centre Nat Rech Scient | Compounds of the amidinium family, pharmaceutical compositions containing these compounds and their use |
-
1999
- 1999-03-30 KR KR1020007010867A patent/KR20010042318A/en not_active Application Discontinuation
- 1999-03-30 IL IL13862599A patent/IL138625A0/en unknown
- 1999-03-30 EP EP99910463A patent/EP1068188A1/en not_active Withdrawn
- 1999-03-30 BR BR9909350-2A patent/BR9909350A/en not_active IP Right Cessation
- 1999-03-30 CN CN99804274A patent/CN1294582A/en active Pending
- 1999-03-30 HU HU0102455A patent/HUP0102455A3/en unknown
- 1999-03-30 CA CA002324931A patent/CA2324931A1/en not_active Abandoned
- 1999-03-30 JP JP2000542302A patent/JP2002513543A/en not_active Withdrawn
- 1999-03-30 PL PL99342886A patent/PL342886A1/en not_active Application Discontinuation
- 1999-03-30 WO PCT/FR1999/000740 patent/WO1999051581A1/en not_active Application Discontinuation
-
2000
- 2000-05-12 AU AU34061/00A patent/AU759301B2/en not_active Ceased
- 2000-09-25 NO NO20004780A patent/NO317225B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2324931A1 (en) | 1999-10-14 |
| AU3406100A (en) | 2000-11-30 |
| JP2002513543A (en) | 2002-05-14 |
| EP1068188A1 (en) | 2001-01-17 |
| HUP0102455A2 (en) | 2001-10-28 |
| KR20010042318A (en) | 2001-05-25 |
| CN1294582A (en) | 2001-05-09 |
| NO317225B1 (en) | 2004-09-20 |
| HUP0102455A3 (en) | 2003-09-29 |
| BR9909350A (en) | 2000-12-12 |
| WO1999051581A1 (en) | 1999-10-14 |
| AU759301B2 (en) | 2003-04-10 |
| NO20004780D0 (en) | 2000-09-25 |
| NO20004780L (en) | 2000-11-01 |
| IL138625A0 (en) | 2001-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL342081A1 (en) | Novel quaternary ammonia compounds, compositions containing them and their application | |
| PL341372A1 (en) | Cellecoxibe containing compositions | |
| HUP0103884A3 (en) | Arylsulfonanilide urea-derivatives, pharmaceutical compositions containing them and their use | |
| HUP0102483A3 (en) | Pharmaceutical compositions containing androst-5-ene-3betha,17betha-diol | |
| PL338186A1 (en) | Beneficial agent compositions containing alpha-hydroxyesters | |
| AU4289399A (en) | Nucleic acid transfer phage | |
| HUP0004375A3 (en) | Composition containing azelaic acid | |
| IL162274A (en) | Nucleic acid and protein designated 193p1e1b and compositions containing the same | |
| PL339920A1 (en) | Synergetic compositions comprising oxathiazine and benzothiophene-2-carboxamido-s,s-dioxide | |
| HUP0102413A3 (en) | Nucleic acid transfer vectors, compositions containing same and uses | |
| EP1208268A4 (en) | Novel quaternary compounds, compositions containing them, and uses thereof | |
| IL142704A0 (en) | Novel nucleic acid transferring agents, compositions containing them and uses | |
| GB9704643D0 (en) | Chemical composition | |
| PL342165A1 (en) | Antienzymic composition containing ethylenediamino disuscinic acid | |
| HUP0102455A3 (en) | Novel nucleic acid transfer agents, compositions containing same and uses | |
| GB9923882D0 (en) | Chemical composition | |
| GB9715908D0 (en) | Chemical composition | |
| ZA992262B (en) | Vectors for transferring nucleic acids, compositions containing them and their uses. | |
| HUP0103006A3 (en) | Substituted betha-diketones, pharmaceutical compositions containing them and their use | |
| EP1135476A4 (en) | Biological compositions, components thereof and uses therefor | |
| GB9819600D0 (en) | Chemical compositions | |
| IL142278A0 (en) | Imidazo-isoquinoline compounds, their compositions and uses | |
| GB9822490D0 (en) | Nucleic acid | |
| GB9715791D0 (en) | Chemical compositions | |
| GB9715792D0 (en) | Chemical compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |